[Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside].
Mimoz
O
O
Laboratoire de microbiologie, département d'anesthésie-réanimation, centre hospitalier universitaire de Poitiers, BP 577, 86021 Poitiers cedex, France. o.mimoz@chu-poitiers.fr
Grollier
G
G
D000617:Aminoglycosides / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000191:economics / Q000382:microbiology; D004359:Drug Therapy, Combination; D006801:Humans; D007769:Lactams / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D014018:Tissue Distribution
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D007769:Lactams